AVALO THERAPEUTICS, INC. Interest Expense
AVALO THERAPEUTICS, INC. (AVTX) reported Interest Expense of $197.47 thousand for the 3-month period ending 2015-09-30, per its 10-Q filed 2015-11-13.
Discontinued › Expense Statement
us-gaap:InterestExpense · last filed 2015-11-13
- AVALO THERAPEUTICS, INC. interest expense for the quarter ending 2015-09-30 was $197.47K, a 4.11% increase year-over-year.
- AVALO THERAPEUTICS, INC. interest expense for the quarter ending 2014-09-30 was $189.68K.
| Period end | Interest Expense 3 month | Interest Expense 9 month |
|---|---|---|
| 2015-09-30 | $197.47K 10-Q · filed 2015-11-13 | $634.77K 10-Q · filed 2015-11-13 |
| 2014-09-30 | $189.68K 10-Q · filed 2015-11-13 | $983.72K 10-Q · filed 2015-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |